VitaNova Life Sciences (VNOV) Shares Outstanding (Weighted Average) (2017 - 2026)

VitaNova Life Sciences has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $8.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $8.3 million; the trailing twelve-month figure through Jan 2026 stood at $8.3 million (changed 0.0% YoY), and the FY2025 full-year result was $25.0 million, up 135.0% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $8.3 million, down from $25.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $25.0 million in Q1 2024, with the low at $5.9 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $13.2 million across 5 years, with a median of $8.3 million in 2025.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) surged 326.01% — and 2025, when it sank 66.67%.
• VitaNova Life Sciences' Shares Outstanding (Weighted Average) stood at $5.9 million in 2022, then changed by 0.0% to $5.9 million in 2023, then surged by 326.01% to $25.0 million in 2024, then changed by 0.0% to $25.0 million in 2025, then plunged by 66.67% to $8.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $8.3 million (Q1 2026), $25.0 million (Q4 2025), and $25.0 million (Q3 2025), per Business Quant data.